- Report
- December 2023
- 295 Pages
Global
€4824EUR$4,995USD£4,128GBP
- Report
- July 2023
- 218 Pages
Global
From €4346EUR$4,500USD£3,719GBP
- Report
- July 2023
- 200 Pages
Global
From €4346EUR$4,500USD£3,719GBP
- Report
- March 2018
- 182 Pages
Global
From €1328EUR$1,375USD£1,136GBP
€2656EUR$2,750USD£2,273GBP
- Report
- October 2022
- 270 Pages
Global
From €3622EUR$3,750USD£3,099GBP
- Report
- February 2018
- 85 Pages
Global
From €5747EUR$5,950USD£4,918GBP
- Report
- March 2022
- 80 Pages
Global
From €734EUR$760USD£628GBP
€918EUR$950USD£785GBP
- Report
- August 2022
- 118 Pages
Global
From €4588EUR$4,750USD£3,926GBP
- Report
- August 2020
- 112 Pages
Global
From €4105EUR$4,250USD£3,513GBP
- Report
- August 2020
- 112 Pages
Global
From €4105EUR$4,250USD£3,513GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2656EUR$2,750USD£2,273GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2656EUR$2,750USD£2,273GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2656EUR$2,750USD£2,273GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2656EUR$2,750USD£2,273GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2656EUR$2,750USD£2,273GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2656EUR$2,750USD£2,273GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2656EUR$2,750USD£2,273GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2656EUR$2,750USD£2,273GBP
- Drug Pipelines
- January 2023
- 30 Pages
Japan
From €2656EUR$2,750USD£2,273GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2656EUR$2,750USD£2,273GBP
The Arthritis Drug market is a subset of the Immune Disorders Drugs market, which includes treatments for a variety of conditions related to the immune system. Arthritis drugs are used to treat the inflammation and pain associated with arthritis, a condition that affects the joints and surrounding tissues. These drugs can be divided into two main categories: non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs). NSAIDs are used to reduce inflammation and pain, while DMARDs are used to slow the progression of the disease.
The Arthritis Drug market is highly competitive, with a number of large pharmaceutical companies offering a variety of treatments. Some of the major players in the market include Pfizer, Merck, AbbVie, Johnson & Johnson, and Novartis. Show Less Read more